Primary Sjögren's syndrome: new beginning for evidence-based trials

A Saraux, V Devauchelle-Pensec - The Lancet, 2022 - thelancet.com
Primary Sjögren's syndrome is a heterogeneous disease that impairs quality of life, mainly
because of sicca, pain, and fatigue, and 15–90% of patients also have systemic …

Primary Sjögren's syndrome: new beginning for evidence-based trials

A Saraux… - Lancet (London …, 2022 - pubmed.ncbi.nlm.nih.gov
Primary Sjögren's syndrome: new beginning for evidence-based trials Primary Sjögren's
syndrome: new beginning for evidence-based trials Lancet. 2022 Jan 8;399(10320):121-122 …

[引用][C] Primary Sjögren's syndrome: new beginning for evidence-based trials.

A Saraux, V Devauchelle-Pensec - Lancet (London, England), 2021 - europepmc.org
Primary Sjögren's syndrome: new beginning for evidence-based trials. - Abstract - Europe
PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools Developers …